Genetic polymorphisms of hemostatic factors and thrombotic risk in non BCR-ABL myeloproliferative neoplasms: A pilot study
The most important complications of Philadelphianegagive (non BCR-ABL) myeloproliferative neoplasms (MPNs) are vascular events. Our aim was to evaluate the effects of single nucleotide polymorphisms (SNPs), platelet glycoproteins (GPs) (Ia/IIa, Ibα, IIb/IIIa and VI), von Willebrand factor (vWF), coa...
Main Authors: | Dambrauskienė R, Gerbutavičius R, Ugenskienė R, Jankauskaitė R, Savukaitytė A, Šimoliūnienė R, Rudžianskienė M, Gerbutavičienė R, Juozaitytė E |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2017-06-01
|
Series: | Balkan Journal of Medical Genetics |
Subjects: | |
Online Access: | https://doi.org/10.1515/bjmg-2017-0005 |
Similar Items
-
Arterial and Venous Thrombosis in Patients with Myeloproliferative Neoplasms
by: Lugyanti Sukrisman
Published: (2019-09-01) -
Can Novel Insights into the Pathogenesis of Myeloproliferative Neoplasm-Related Thrombosis Inform Novel Treatment Approaches?
by: Ofir Wolach, et al.
Published: (2021-05-01) -
Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India
by: Nikhil Rabade, et al.
Published: (2018-01-01) -
Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
by: Michelle Maccarini Barcelos, et al.
Published: (2011-01-01) -
Thrombosis in patients with myeloproliferative neoplasms. Case report
by: Anait L. Melikyan, et al.
Published: (2021-07-01)